NeOnc Technologies Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for intracranial malignancies. Its lead product candidates include NEO100, a purified form of preillyl acid that is in Phase IIa clinical trial; and NEO212, a covalently conjugated molecule combining chemotherapeutic drug temozolomide with perillyl alcohol that is in Phase I/II clinical trials for its oral administration for the treatment of primary brain cancers, such as meningioma, high grade gliomas, glioblastoma, and secondary brain cancers. The company was formerly known as NAS-ONC, Inc. and changed its name to NeOnc Technologies Holdings, Inc. in 2009. The company was incorporated in 2005 and is headquartered in Calabasas, California.
Frequently asked questions
What sector does NeOnc Technologies Holdings, Inc. Common Stock (NTHI) operate in?
NeOnc Technologies Holdings, Inc. Common Stock belongs to the Healthcare sector and operates in the Biotechnology industry.
What is NeOnc Technologies Holdings, Inc. Common Stock (NTHI) current stock price?
As of the latest data, NeOnc Technologies Holdings, Inc. Common Stock stock price is $2.94, with a previous close of $2.82. NeOnc Technologies Holdings, Inc. Common Stock gained $0.12 in the last trading session, representing a 4.26% increase.
What is NeOnc Technologies Holdings, Inc. Common Stock (NTHI) current market capitalization?
NeOnc Technologies Holdings, Inc. Common Stock market cap is approximately 84.69 million.
What is NeOnc Technologies Holdings, Inc. Common Stock (NTHI) Earnings Per Share (EPS)?
The trailing EPS is -$2.12, and the forward EPS is -$1.09.
What is NeOnc Technologies Holdings, Inc. Common Stock (NTHI) EBITDA?
NeOnc Technologies Holdings, Inc. Common Stock EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -14.04 million.
Does NeOnc Technologies Holdings, Inc. Common Stock (NTHI) pay dividends?
No. NeOnc Technologies Holdings, Inc. Common Stock does not pay a dividend.
When is NeOnc Technologies Holdings, Inc. Common Stock (NTHI) next earnings report?
NeOnc Technologies Holdings, Inc. Common Stock is expected to release its next earnings report on September 30, 2026.
What is NeOnc Technologies Holdings, Inc. Common Stock (NTHI) beta (volatility) score?
NeOnc Technologies Holdings, Inc. Common Stock has a beta of -0.226, indicating lower volatility than the overall market.
